Verge Genomics

Currently, it takes 12 years and $2.6 billion to get a single drug to market, with the drug discovery and development process costing $1.4 billion. At Verge Genomics, we believe there is a better way: we aim to improve the traditional drug discovery process with approaches based on systems biology, machine learning on human patient data, and drug screening in human cell cultures. We’ve raised $32 million in Series A financing to build a next-generation biopharmaceutical company focused on accelerating development of life-saving treatments for patients with neurodegenerative diseases, including ALS, Parkinson’s Disease, and Alzheimer’s Disease. Values: Team of Founders – Ready to roll up our sleeves to get things done ?? Curiosity – Choose wonder over being right ??‍♀️ Patient Focused – Inspired and driven by the people who need us ♥️ Transparency and Autonomy – Empowered to make decisions and express ourselves with candor ? Growth Mindset – Treat every interaction as an opportunity to learn ? Grit In the Face of Adversity -- Embrace challenges and persist against all odds More about you: As an emerging startup, Verge Genomics provides growth opportunities into other areas of the company. Being one of the early employees at Verge, your work will have a direct impact on the foundation of a groundbreaking new drug development model. You will be empowered to own your work and makes real decisions. In addition to competitive compensation and benefits, we offer perks like unlimited vacation/sick days, and free lunch delivered every day.